Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-004549
Filing Date
2015-03-09
Accepted
2015-03-09 18:02:04
Documents
1
Period of Report
2015-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6450
  Complete submission text file 0001179110-15-004549.txt   7830
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Issuer) CIK: 0001578845 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
DArecca James (Reporting) CIK: 0001583903 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36867 | Film No.: 15686434